T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.61% |
| 2 | Healthcare | 16.74% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Financials | 11.46% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HR
526
DELISTED
Healthcare Realty Trust Incorporated
HR
| $168M | 0.02% |
5,583,159
+111,261
| +2% | +$3.2M |
|
527
Pennant Group
PNTG
$1.35B
| $166M | 0.02% |
4,313,241
-18,824
| -0.4% | -$577K |
|
528
Popular Inc
BPOP
$11.3B
| $166M | 0.02% |
4,570,174
+948,618
| +26% | +$35.1M |
|
529
Grupo Aeroportuario del Sureste
ASR
$8.01B
| $166M | 0.02% |
1,428,535
+248,479
| +21% | +$27M |
|
530
Trex
TREX
$5.1B
| $166M | 0.02% |
2,314,806
-1,230,540
| -35% | -$85.1M |
|
531
FTI Consulting
FCN
$4.24B
| $166M | 0.02% |
1,563,602
-119,989
| -7% | -$13.6M |
|
532
Citigroup
C
$233B
| $165M | 0.02% |
3,825,842
-1,438,891
| -27% | -$71.7M |
|
533
Cavco Industries
CVCO
$4.67B
| $163M | 0.02% |
905,864
-1,223
| -0.1% | -$233K |
|
534
Mattel
MAT
$4.25B
| $160M | 0.02% |
13,673,232
+121,235
| +0.9% | +$1.35M |
|
535
Asana
ASAN
$2.28B
| $160M | 0.02% |
+5,548,584
| New | +$160M |
|
|
KYNB
536
Kyntra Bio
KYNB
$28.5M
| $158M | 0.02% |
154,035
-10,650
| -6% | -$11.5M |
|
537
Tencent Music
TME
$14.2B
| $158M | 0.02% |
10,712,157
-457,657
| -4% | -$7.14M |
|
538
UFP Industries
UFPI
$5.03B
| $157M | 0.02% |
2,773,054
+573,755
| +26% | +$32.4M |
|
|
SAGE
539
DELISTED
Sage Therapeutics
SAGE
| $156M | 0.02% |
2,559,034
-260,018
| -9% | -$13.2M |
|
540
Denali Therapeutics
DNLI
$3.97B
| $156M | 0.02% |
4,360,975
+1,738,813
| +66% | +$52.4M |
|
541
Ralph Lauren
RL
$23.1B
| $156M | 0.02% |
2,298,308
+632,735
| +38% | +$45.1M |
|
|
HZNP
542
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $155M | 0.02% |
1,994,086
-1,172,812
| -37% | -$80.7M |
|
543
Targa Resources
TRGP
$57.2B
| $155M | 0.02% |
11,036,498
+705,299
| +7% | +$12.4M |
|
544
Allegion
ALLE
$14.2B
| $155M | 0.02% |
1,564,157
-5,911
| -0.4% | -$600K |
|
545
First Industrial Realty Trust
FR
$8.4B
| $151M | 0.02% |
3,802,000
-146,530
| -4% | -$6.05M |
|
546
Tandem Diabetes Care
TNDM
$1.61B
| $151M | 0.02% |
1,328,688
+256,413
| +24% | +$26.9M |
|
547
Knight Transportation
KNX
$11.9B
| $150M | 0.02% |
3,681,519
-3,859
| -0.1% | -$169K |
|
548
St. Joe Company
JOE
$3.89B
| $150M | 0.02% |
7,249,485
+105,093
| +1% | +$2.2M |
|
549
BioMarin Pharmaceuticals
BMRN
$13.3B
| $149M | 0.02% |
1,955,282
+515,857
| +36% | +$52.2M |
|
550
The Ensign Group
ENSG
$10.6B
| $148M | 0.02% |
2,599,512
-845
| -0% | -$43.6K |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.